Supramolecular Synthons in Bumetanide Cocrystals and Ternary Products
journal contributionposted on 30.06.2017, 00:00 by Suryanarayana Allu, Geetha Bolla, Srinu Tothadi, Ashwini Nangia
A novel design strategy for cocrystals of the diuretic sulfonamide drug bumetanide (BUM) with carboxamides is reported based on reliable supramolecular synthons. Binary cocrystals of BUM with pyridine carboxamides, pyridones, and cytosine were obtained by solvent-assisted grinding followed by solution crystallization. All cocrystal structures exhibit hydrogen bonding of the coformer with the carboxylic acid group of BUM via heterosynthons which replace the acid homodimer in the drug crystal structure. Pyridones are inserted as N–H···O dimers which are in turn bonded to the acid group of BUM, while the pyridine amide coformers interact via the acid–amide heterosynthon. Cocrystal polymorphs were obtained for bumetanide–isonicotinamide cocrystal structure with the sulfonamide–pyridine and sulfonamide–acid synthons. Careful crystal packing analysis of BUM structure and nine new binary adducts gave an idea for the design ternary cocrystals, and subsequently four new ternary crystalline products were crystallized. Whereas the binary cocrystal structures were confirmed by single crystal diffraction, the ternary combinations were characterized by their unique powder X-ray diffraction patterns as well as by thermal and spectroscopic techniques.
Read the peer-reviewed publication
pyridine amide coformersSupramolecular Synthonsternary combinationssupramolecular synthonsBinary cocrystalsacid groupcocrystal structurescrystal diffractionspectroscopic techniquesdiuretic sulfonamide drug bumetanidedrug crystal structureacid homodimercocrystal structures exhibit hydrogenBumetanide Cocrystalspowder X-ray diffraction patternssolution crystallizationCareful crystalBUM structuredesign ternary cocrystalspyridine carboxamidesCocrystal polymorphsnovel design strategyTernary Productscarboxylic acid group